|
|
|
|
Click on a highlighted title to read the PDF.
| APTIMA®
for Chlamydia trachomatis and Neisseria gonorrhoeae - Posters |
| Title |
Primary
Author and Affiliation |
Poster
- Where & When Presented |
| Performance of Nucleic
Acid Amplification Tests (NAATs) for Chlamydia and Gonococcal
Infections of the Oropharynx and Rectum |
Klausner; San Francisco
DOH, San Francisco, CA |
Poster
2004 American Society of Microbiology Meeting |
| Evaluation of the
APTIMA CT Assay as a Direct and Confirmatory Method for the Detection
of Chlamydia trachomatis |
LeBar; Hospital
Consolidated Services, Southfield, MI |
Poster
2004 Clinical Virology Meeting |
| Use of M4 Transport
Medium for Detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) with the APTIMA Combo 2, APTIMA
CT and APTIMA GC Assays |
LeBar;
Hospital Consolidated Services, Southfield, MI |
Poster
2004 American Society of Microbiology Meeting |
| Use of the APTIMA Combo 2 Test
for Chlamydia trachomatis and Neisseria gonorrhoeae in Pharyngeal and Rectal Specimens |
Ferrero;
San Joaquin PH, Stockton, CA |
Poster
2003 American Society of Microbiology Meeting |
| Simultaneous Detection of Chlamydia
trachomatis and Neisseria gonorrhoeae in the APTIMA
Combo 2 Assay by Testing Cervical Swabs Previously tested by LCx
or ProbeTec Assays |
Chernesky; St. Joseph's Hospital,
Hamilton, Canada |
Poster
2002 European Congress of Clinical Microbiology and Infectious
Disease |
| APTIMA®
General Purpose Reagents (GPR) - Posters |
| Title |
Primary Author and Affiliation |
Poster
- Where & When Presented |
Semi-Automated and
Fully Automated Viral Transcription-Medicated Amplification Nucleic
Acid Test Assay Development Using General Purpose Reagents
|
Getman; Gen-Probe
Incorporated, San Diego, CA
|
Poster
2004 Clinical Virology Meeting |
| APTIMA®
Analyte Specific Reagents (ASR) for Trichomonas vaginalis - Posters |
| Title |
Primary
Author and Affiliation |
Poster
- Where & When Presented |
| Evaluation of the Papanicolaou Stain Versus APTIMA® Trichomonas vaginalis Analyte Specific Reagents for the Detection of Trichomonas vaginalis from Cytyc® ThinPrep Vials |
Fuller; Wishard Health Services Indiana University, IN |
Poster
2007 American Society of Microbiology Meeting |
| Evaluation of Real-Time PCR
and Transcription-Mediated Amplification for Detection of Trichomonas
vaginalis in Urine |
Hobbs; The University of North
Carolina at Chapel Hill, Chapel Hill, NC |
Poster
2006 American Society of Microbiology Meeting |
| Use of Gen-Probe APTIMA®
Tests to Detect Multiple Etiologies of Urethritis and Cervicitis
in Sexually Transmitted Disease (STD) Clinics |
Gaydos; The Johns Hopkins University,
Baltimore, MD |
Poster
2006 American Society of Microbiology Meeting |
| Comparison of Cervical
Samples to vaginal Samples for the Detection of Trichomonas
vaginalis Using a GEN-PROBE Research Assay for rRNA |
Gaydos; The Johns
Hopkins University, Baltimore, MD |
Poster
2005 American Society of Microbiology Meeting |
| Comparison between
the research GEN-PROBE APTIMA formatted assay for rRNA (AMP-TV)
and a real-time PCR, B-TUB FRET, for the detection of Trichomonas
vaginalis |
Gaydos; The Johns
Hopkins University, Baltimore, MD |
Poster
2005 American Society of Microbiology Meeting |
| Comparison of Transcription-Mediated
Amplification, culture and PCR methods for detection of Trichomonas
vaginalis |
Getman; Gen-Probe Incorporated,
San Diego, CA |
Poster
2005 Scheveningen Molecular Meeting |
| Detection of Trichomonas
vaginalis (TV) in Female Urine and Vaginal Specimens Using
a Transcription-Mediated Amplification (TMA) Assay |
Martin; LSU Health
Sciences Center and the Gulf South STI TM Cooperative Research
Center, New Orleans, LA |
Poster
2005 International Society for Sexually Transmitted Diseases Research |
| Rapid Detection of Trichomonas
vaginalis from Vaginal Specimens by Transcription-Mediated
Amplification |
Sitay; Gen-Probe Incorporated,
San Diego, CA |
Poster
2003 American Society of Microbiology Meeting |
| APTIMA®
HIV-1 RNA Qualitative Assay |
| Title |
Primary Author and Affiliation |
Poster
- Where & When Presented |
Evaluation of the Gen-Probe APTIMA HIV-1 RNA Qualitative Assay for the Detection of HIV-1 in Plasma
|
Hodinka, R.L; The Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
|
Poster 2009 Clinical Virology Symposium, Daytona Beach, FL |
| Detection of HIV-1 in alternative specimen types using the APTIMA HIV-1 RNA Qualitative Assay |
Nugent CT, Dockter J, Bernardin F, Hecht R, Smith D, Delwart E, Pilcher C, Richman D, Busch M, Giachetti C; Gen-Probe Incorporated, San Diego, CA |
J Virol Methods. 2009 Jul;159(1):10-4 |
Evaluation of a highly sensitive qualitative human immunodeficiency virus type 1 (HIV-1) RNA assay for detection of HIV-1 suppression |
Nugent CT, Nodelman V, Giachetti C, Richman DD, Looney DJ; Gen-Probe Incorporated, San Diego, CA
|
J Clin Microbiol. 2009 Mar; 47(3):833-6 |
| AMPLIFIED MTD®
(Mycobacterium Tuberculosis Direct) Test |
| Title |
Primary Author and Affiliation |
Poster
- Where & When Presented |
Updated Guidelines for the Use and Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis
|
CDC Div of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
|
2009 / 68(01); 7-10 |
| Use of the Amplified Mycobacterium tuberculosis Direct Test in a Public Health Laboratory |
Renata, GL et al; American College of Chest Physicians |
Chest 2007; 132; 946-951 |
| APTIMA® HPV |
| Title |
Primary
Author and Affiliation |
Poster
- Where & When Presented |
| Performance of APTIMA HPV Assay in Referral Population |
Getman; Gen-Probe Incorporate, San Diego, California |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| Evaluation of the APTIMA Cervical Specimen Collection and Transport Kit |
Nugent; Gen-Probe Incorporate, San Diego, California |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| Comparison of Three High-Risk HPV (HR-HPV) Tests on ASC Samples with Follow-up |
Schledemann: Odense University Hospital, Denmark |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| Performance of HPV E6/E7 mRNA and DNA Tests for the Detection of CIN or Worse: Results from a Multicentre Canadian Study |
Ratnam; Public Health Laboratory, St. John's, Canada |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| Results of the French APTIMA HPV Screening Evaluation (FASE Study) |
Monsonego; European Institute of the Cervix, Paris |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| Detection of HPV mRNA in Cytology Specimens with the APTIMA HPV HPV Assay |
Clad; Universitaets-Frauenklinik, Freiburg, Germany |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| Does RNA Testing Detect Clinically Significant HPV Infection? |
Cuschieri; Royal Infirmary of Edinburgh |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| HPV mRNA and p16INK4a as Triage Markers in Cervical Cytology |
Reuschenbach; University of Heidelberg, Heidelberg, Germany |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| Characterization
of a Prototype Transcription-Mediated Amplification (TMA) Based
Diagnostic Assay for Detection of HPV E6/E7 mRNA in LBC Media |
Kolk; Gen-Probe
Incorporated, San Diego, CA |
Poster
2006 EUROGIN, Paris, France |
| PCA3 |
| Title |
Primary
Author and Affiliation |
Publication |
| PCA3 Urine mRNA Testing for Prostate Carcinoma: Patterns of Use by Community Urologists and Assay Performance in Reference Laboratory Setting. |
Shappell, SB et al.; Molecular Oncology Diagnostic Laboratory, Dallas, TX |
J.Urol. 2008. Accepted August 4, 2008. |
| PCA3 Score Before Radical Prostatectomy Predicts Extracapsular Extension (ECE) and Tumor Volume. |
Whitman, EJ et al.; Walter Reed Army Medical Center, Washington, DC |
J Urol. 2008(180), 1975-1979. |
| Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical Practice. |
Marks, LS et al.; Geffen School of Medicine at UCLA, Los Angeles, CA |
Rev Urol. 2008, 10(3), 175-181 |
| Predicting Prostate Cancer Risk Through Incorporation of Prostate Cancer Gene 3. |
Ankerst, DP et al.; University of Texas Health Sciences Center, San Antonio, TX |
J Urol. 2008, 180(4), 1303-1308. |
| Clinical utility of prostate carcinoma molecular diagnostic tests. |
Shappell, SB; Mosaic Diagnostics, Dallas, TX |
Rev Urol. 2008, 10(1), 44-69. |
| Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy. |
Haese, A. et al.; University Clinic Hamburg, Germany |
Eur Urol. 2008(54), 1081-1088. |
| Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results. |
van Gils, MP et al.; Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands |
Prostate. 2008, 68(11), 1215-22. |
| PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance. |
Nakanishi, H.; The University of Texas M. D. Anderson Cancer Center, Houston, TX. |
J Urol. 2008, 179, 1804-9. |
| PCA3: A molecular urine assay for predicting prostate biopsy outcome
|
Deras, IL et al.; Gen-Probe, Inc., San Diego, CA
|
J Urol. 2008, 179(4), 1587-92. |
| Newer potential biomarkers in prostate cancer. |
Wright, JL et al.; University of Washington School of Medicine, Seattle, WA |
Rev Urol. 2007, 9(4), 207-13. |
| A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy. |
Sokoll, LJ, et al.; Johns Hopkins Medical Institutions, Baltimore, MD |
Clin Chim Acta. 2008, 389(1-2), 1-6. |
| PROGENSA® PCA3 test for prostate cancer detection. |
de la Taille, A. ; Henri Mondor Hospital, Créteil, France |
Expert Rev Mol Diagn. 2007, 7(5), 491-7. |
| Molecular PCA3 diagnostics on prostatic fluid. |
van Gils, MP et al.; Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands |
Prostate. 2007, 67(8), 881-7. |
| PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. |
Marks, LS et al.; Urological Sciences Research Foundation, Los Angeles, CA |
Urology. 2007, 69(3), 532-5. |
| Molecular markers for prostate cancer. |
Reynolds, MA et al.; Gen-Probe Incorporated, San Diego, CA |
Cancer Lett. 2007, 249(1), 5-13. |
| APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. |
Groskopf, J et al.; Gen-Probe Incorporated, San Diego, CA |
Clin Chem. 2006, 52(6), 1089-95. |
*ASR (Analyte
Specific Reagent): Analytical and performance characteristics are
not established.
|
|
